← FDA DRUG APPROVALS

FDA ANDA · ANDA077238

ZALEPLON

Sponsor: NATCO PHARMA

APPLICATION
ANDA077238
TYPE
ANDA
ORIGINAL APPROVAL
2008-06-06
LATEST ACTION
2024-06-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

ZALEPLONDiscontinued
ZALEPLON 10MG · CAPSULE · ORAL
ZALEPLONDiscontinued
ZALEPLON 5MG · CAPSULE · ORAL

Approval history

2024-06-13Labeling · Supplement 8 · standardAP
2015-07-06Labeling · Supplement 5 · standardAP
2008-06-06OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →